Postoperative pain managed with opioids has contributed to the opioid crisis through over-prescribing practices. We assessed opioid-prescribing habits and their use by patients undergoing surgery for cutaneous malignancies. An Institutional Review Board–approved retrospective analysis was conducted for patients who underwent skin cancer resection between January 2018 and June 2018. Data were collected from the electronic medical record, and opioid-related data were collected from patient interviews and state registries. There were 120 study participants (42 females and 78 males) with a median age of 67 years (range, 21–94 years). All received preincision local anesthetic: 64 had liposomal bupivacaine (LB) (53%) and 56 had non-LB bupivacaine (47%). Most participants (n = 88) used 0 opioids (73%), including 43 LB-anesthetic (67%) and 45 non–LB-anesthetic (80%). No significance was seen between those with a diagnosis of chronic pain, narcotic tolerance, an area of resection, and nodal sampling groups in opioid use. Four patients (3%) requested a refill. Of 105 prescriptions written for opioids, 99 had leftover opioids for an over-prescribing rate of 94 per cent. This study suggests pain after skin cancer surgery is manageable with very limited opioid requirements. Our results support prescribing no more than five opioid tablets for postoperative pain control in patients undergoing resection for skin malignancies.
HarrisK., CurtisJ., LarsenB.Opioid pain medication use after dermatologic surgery.JAMA Dermatol2013; 149: 317–21.
7.
HarrisK., CalderS., LarsenB.Opioid prescribing patterns after Mohs micrographic surgery and standard excision.Dermatol Surg2014; 40: 906–11.
8.
WunschH., WijeysunderaD.N., PassarellaM.A.Opioids prescribed after low-risk surgical procedures in the United States, 2004–2012.JAMA2016; 315: 1654–7.
9.
HowardR., WaljeeJ., BrummettC.Reduction in opioid prescribing through evidence-based prescribing guidelines.JAMA Surg2018; 153: 285–7.
10.
HillM.V., McmahonM.L., StuckeR.S.Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures.Ann Surg2017; 265: 709–14.
11.
AlamA., GomesT., ZhengH.Long-term analgesic use after low-risk surgery: a retrospective cohort study.Arch Intern Med2012; 172: 425–30.
12.
MakaryM.A., OvertonH.N., WangP.Overprescribing is major contributor to opioid crisis.BMJ2017; 359: j4792.
13.
FDA.Extended-release (ER) and long-acting (LA) opioid analgesics risk evaluation and mitigation strategy (REMS). Available at: https://www.fda.gov/media/83883/download. Accessed February 11, 2019.
Washington State Agency Medical Directors’ Group. Interagency Guideline on Prescribing Opioids for Pain. Available at: http://www.agencymeddirectors.wa.gov/guidelines.asp. 2015. Accessed February 20, 2019.
16.
Washington State Agency Medical Directors’ Group. Prescribing Opioids for Postoperative Pain – Supplemental Guidance. Available at: agencymeddirectors.wa.gov/Files/FinalSupBreeAMDGPostopPain091318wcover.pdf. 2018. Accessed February 20, 2019.
LutzJ., GrossR.T., VargovichA.M.Difficulties in emotion regulation and chronic pain-related disability and opioid misuse.Addict Behav2018; 87: 200–5.
20.
HilliardP.E., WaljeeJ., MoserS.Prevalence of pre-operative opioid use and characteristics associated with opioid use among patients presenting for surgery.JAMA Surg2018; 153: 929–37.
21.
Centers for Disease Control and Prevention.CDC guideline for prescribing opioids for chronic pain—United States, 2016. Available at: https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm. Accessed March 18, 2016.
22.
MchughR.K., WeissR.D., CorneliusM.Distress intolerance and prescription opioid misuse among patients with chronic pain.J Pain2016; 17: 806–14.
23.
FeingoldD., BrillS., Goor-AryehI.The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: a cross-sectional study.J Affect Disord2018; 235: 293–302.
